Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.700
-0.570 (-13.35%)
At close: Oct 6, 2026, 4:00 PM EDT
3.640
-0.060 (-1.62%)
After-hours: Oct 6, 2026, 4:52 PM EDT
Aclaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $13 | Buy | Maintains | $13 | +251.35% | Oct 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $10 | Buy | Initiates | $10 | +170.27% | Sep 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 | Buy | Maintains | $11 | +197.30% | Aug 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +332.43% | Aug 10, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $10 | Buy | Maintains | $10 | +170.27% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $12 | Buy | Reiterates | $12 | +224.32% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $10 | Buy | Maintains | $10 | +170.27% | May 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +170.27% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.